The recent study of reports and data suggests that the Breast Biopsy Market is expected to attain a market value of USD 1.51 Billion by 2027 the end the forecast frame registering a CAGR of 10.8%. Breast Biopsy refers to a diagnostic procedure to determine whether a small sample removed from the breast tissue is cancerous. It is regarded as the most effective methods for cancer diagnosis. It is found that about 70-80% of the biopsies are negative of cancer, but may diagnose conditions that are predispose to mammary carcinoma. Breast biopsy is recommended when a person is facing symptoms like a breast lump, sore breast, breast dimpling, peel appearance to breast and nipple discharge etc. The invasive surgical methods for breast biopsy has been found to be disadvantageous as it is painful and the patient will have to bear the psychological stress of false positive referrals.
The increasing vulnerability of women to mammary carcinoma in all the economies, along with the awareness drives and screenings conducted in favor of women have propelled the demand side of the breast biopsy market. The extensive and exhaustive research environment acts as an impetus to the market which has aided in evolving more accurate and minimally invasive methods for the early diagnosis of mammary carcinoma. The governments have also worked towards building a continuous and comprehensive environment for cancer research which has fueled the growth of these diagnostic devices. Also favorable reimbursements in this regard has improved the state of this market drastically. The growth of these diagnostic devices are impeded by the prevalence of side effects and infections after the biopsy. Stringent regulations by the USFDA and other notifying authorities along with high cost of these services have worked against the unrestricted growth of the market.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/2022
Further Key Finding from the report
- The mammary carcinoma is found to be the most common invasive cancer among women and affects women in both developed and developing countries. Hence the target consumers for breast biopsy is women above the age of 40. The growing awareness of breast cancer has fueled the demand for this market
- The American Cancer society has confirmed that there has been a decline in deaths caused by breast cancer reason being that cancer have been detected earlier through mammography, making it the most effective screening method
- Thermography was popularized as it was a method to produce infrared images of head and blood flow near the surface of the body, but it was found that it lacked the ability to detect cancer at the early stage
- Advancements and innovations are carried out in the product segment. Stryker, an innovator in the given field have brought in PreciseCore needles which have been used for improved precision and minimal tissue damage.
- Asia-Pacific regional segment of the breast biopsy market is expected to remain highest growing segment during 2019-2026, at a CAGR of 12.1%; owing it to increase in medical awareness and untapped opportunities in India and China due to rising pool of vulnerable geriatric women with awareness about mammary carcinoma. However, conventional methods like surgery and needle rule the market.
- Currently the vacuum assisted breast biopsy has dominated over the market and is the fastest growing segment as it overcomes the drawbacks of the conventional needle based methods which is inherently characterized with inaccuracy. It is growing at a CAGR of 10.9%.
Competitive Outlook of the Global Breast Biopsy Market
The globla Breast Biopsy market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Breast Biopsy market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.
Top Companies Profiled in the Report:
Becton, Dickinson and Company, C.R. Bard, Inc., Devicor Medical Products Inc., Hologic Inc., Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC, Planmed OY, and Ethicon Endo Surgery (Johnson and Johnson), among others.
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2022
The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.
Breast Biopsy Market Segmentation:
Type (Revenue, USD Million; 2017–2027)
- Needle Breast Biopsy
- Vacuum Assisted Surgery
- Core needle Biopsy
- Fine Needle Aspiration Biopsy
- Open Surgical Breast Biopsy
- Incisional
- Excisional
Product (Revenue, USD Million; 2017–2027)
- Biopsy Needles
- Biopsy Tables
- Guidance Systems
- Localization Wires
- Punches
- Markers
- Sutures
Guidance Type (Revenue, USD Million; 2017–2027)
- Mammography
- Ultra sound
- MRI
- CT scan
- Others
End Use (Revenue, USD Million; 2017–2027)
- Diagnostic Clinic
- Hospitals
- Others
Geographic Segment Covered in the Report:
The Breast Biopsy report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
- North America (USA and Canada)
- Europe (UK, Germany, France and the rest of Europe)
- Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
- Latin America (Brazil, Mexico, and the rest of Latin America)
- Middle East and Africa (GCC and rest of the Middle East and Africa)
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2022
Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.
Get Explore Latest Research Report by Reports and Data:
Galantamine Hydrobromide Market @ https://www.biospace.com/article/galantamine-hydrobromide-market-size-industry-statistics-growth-potentials-trends-company-profile-global-expansion-strategies-by-top-key-vendors-till-2028/
Acute Viral Rhinosinusitis Treatment Market @ https://www.biospace.com/article/acute-viral-rhinosinusitis-treatment-market-share-size-key-players-trends-competitive-and-regional-forecast-to-2028/
Tuberculosis Testing Market @ https://www.biospace.com/article/tuberculosis-testing-market-insights-future-trends-on-going-demand-opportunities-segmentation-and-forecast-till-2028/
Spinal Traction Market @ https://www.biospace.com/article/spinal-traction-market-size-share-growth-sales-revenue-and-key-drivers-analysis-research-report-by-2028/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
